Clinical acceptability study of micronized purified flavonoid fraction 1000 mg tablets versus 500 mg tablets in patients suffering acute hemorrhoidal disease.

Autor: Shelygin Y; a State Scientific Center of Coloproctology, Ministry of Health of Russian Federation , Moscow , Russia., Krivokapic Z; b Institute for Digestive Diseases, Clinical Center of Serbia , Belgrade , Serbia., Frolov SA; a State Scientific Center of Coloproctology, Ministry of Health of Russian Federation , Moscow , Russia., Kostarev IV; a State Scientific Center of Coloproctology, Ministry of Health of Russian Federation , Moscow , Russia., Astashov VL; c Burdenko General Military Clinical Hospital, Consultative Diagnostic Centre , Moscow , Russia., Vasiliev SV; d City Clinical Hospital No. 9, Saint-Petersburg Scientific Practical Centre of Coloproctology , Saint-Petersburg , Russia., Lakhin AV; e Lipetsk Regional Clinical Hospital , Department of Coloproctology 6A , Lipetsk , Russia., Rodoman GV; f City Clinical Hospital No. 24, Moscow City Centre of Coloproctology , Moscow , Russia., Soloviev AO; g ZAO Medical Scientific Productive Establishment Dvizhenie , Volgograd., Stoyko YM; h National Pirogov Medical Surgical Centre, Phlebology Service , Moscow , Russia., Khitaryan AG; i Railway Clinical Hospital on Rostov-Glavniy Railway Station , 1st Surgery Department , Rostov-on-Don , Russia., Nechay IA; f City Clinical Hospital No. 24, Moscow City Centre of Coloproctology , Moscow , Russia.

Publikováno v: Current medical research and opinion [Curr Med Res Opin] 2016 Nov; Vol. 32 (11), pp. 1821-1826. Date of Electronic Publication: 2016 Aug 25.